Back to search

Article

A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern <i>in vitro</i> and <i>in vivo</i>

2021-06-28

Abstract excerpt

<h4>ABSTRACT</h4> Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged at the end of 2019 and has been responsible for the still ongoing coronavirus disease 2019 (COVID-19) pandemic. Prophylactic vaccines have been authorized by the United States (US) Food and Drug Administration (FDA) for the prevention of COVID-19. Identification of SARS-CoV-2 neutralizing antibodies (NAbs) is important to asses...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5fd25eaf-486e-53e0-b999-bf6fb68fa328
DOI
10.1101/2021.06.28.450214
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern <i>in vitro</i> and <i>in vivo</i>DOI 10.1101/2021.06.28.450214
A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo.Semantic proximity
An <i>in vitro</i> experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodiesSemantic proximity
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variantsSemantic proximity
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variantsSemantic proximity
Detection and Quantification of Antibody to SARS-CoV-2 Receptor Binding Domain Provides Enhanced Sensitivity, Specificity and UtilitySemantic proximity
Development and characterization of neutralizing antibodies against SRAS-CoV-2Semantic proximity
A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screeningSemantic proximity
Development of Monoclonal Antibodies Against SARS-CoV-2 Nucleocapsid Protein for COVID-19 Antigen DetectionSemantic proximity
SARS-CoV-2 assays to detect functional antibody responses that block ACE2 recognition in vaccinated animals and infected patientsSemantic proximity
Microscopy-based assay for semi-quantitative detection of SARS-CoV-2 specific antibodies in human seraSemantic proximity
Development of a SARS-CoV-2 monoclonal antibody panel and its applicability as a reagent in high-throughput fluorescence reduction neutralization and immunohistochemistry assaysSemantic proximity
Rapid homogeneous assay for detecting antibodies against SARS-CoV-2Semantic proximity
Select a neighboring publication to make it the new centre.